Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81,719 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.
Zhou GQ, Tang LL, Mao YP, Chen L, Li WF, Sun Y, Liu LZ, Li L, Lin AH, Ma J. Zhou GQ, et al. Among authors: chen l. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e359-65. doi: 10.1016/j.ijrobp.2011.06.1967. Epub 2011 Oct 12. Int J Radiat Oncol Biol Phys. 2012. PMID: 22000748
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.
Chen L, Hu CS, Chen XZ, Hu GQ, Cheng ZB, Sun Y, Li WX, Chen YY, Xie FY, Liang SB, Chen Y, Xu TT, Li B, Long GX, Wang SY, Zheng BM, Guo Y, Sun Y, Mao YP, Tang LL, Chen YM, Liu MZ, Ma J. Chen L, et al. Among authors: chen yy, chen ym, chen xz, chen y. Lancet Oncol. 2012 Feb;13(2):163-71. doi: 10.1016/S1470-2045(11)70320-5. Epub 2011 Dec 7. Lancet Oncol. 2012. PMID: 22154591 Clinical Trial.
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.
Sun Y, Li WF, Chen NY, Zhang N, Hu GQ, Xie FY, Sun Y, Chen XZ, Li JG, Zhu XD, Hu CS, Xu XY, Chen YY, Hu WH, Guo L, Mo HY, Chen L, Mao YP, Sun R, Ai P, Liang SB, Long GX, Zheng BM, Feng XL, Gong XC, Li L, Shen CY, Xu JY, Guo Y, Chen YM, Zhang F, Lin L, Tang LL, Liu MZ, Ma J. Sun Y, et al. Among authors: chen yy, chen l, chen ym, chen xz, chen ny. Lancet Oncol. 2016 Nov;17(11):1509-1520. doi: 10.1016/S1470-2045(16)30410-7. Epub 2016 Sep 27. Lancet Oncol. 2016. PMID: 27686945 Clinical Trial.
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial.
Chen L, Hu CS, Chen XZ, Hu GQ, Cheng ZB, Sun Y, Li WX, Chen YY, Xie FY, Liang SB, Chen Y, Xu TT, Li B, Long GX, Wang SY, Zheng BM, Guo Y, Sun Y, Mao YP, Tang LL, Chen YM, Liu MZ, Ma J. Chen L, et al. Among authors: chen yy, chen ym, chen xz, chen y. Eur J Cancer. 2017 Apr;75:150-158. doi: 10.1016/j.ejca.2017.01.002. Epub 2017 Feb 22. Eur J Cancer. 2017. PMID: 28235726 Clinical Trial.
Induction Chemotherapy Improved Long-term Outcomes of Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Matched Analysis of 5-year Survival Outcomes in the Era of Intensity-modulated Radiotherapy.
Peng H, Chen L, Zhang J, Li WF, Mao YP, Zhang Y, Liu LZ, Tian L, Lin AH, Sun Y, Ma J. Peng H, et al. Among authors: chen l. J Cancer. 2017 Feb 10;8(3):371-377. doi: 10.7150/jca.16732. eCollection 2017. J Cancer. 2017. PMID: 28261337 Free PMC article.
Establishing and applying nomograms based on the 8th edition of the UICC/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy.
Xu C, Chen YP, Liu X, Li WF, Chen L, Mao YP, Zhang Y, Guo R, Zhou GQ, Tang LL, Lin AH, Sun Y, Ma J. Xu C, et al. Among authors: chen l, chen yp. Oral Oncol. 2017 Jun;69:99-107. doi: 10.1016/j.oraloncology.2017.04.015. Epub 2017 May 2. Oral Oncol. 2017. PMID: 28559028
Reporting Quality of Randomized, Controlled Trials Evaluating Combined Chemoradiotherapy in Nasopharyngeal Carcinoma.
Chen YP, Chen L, Li WF, Lee AWM, Vermorken JB, Wee J, O'Sullivan B, Eisbruch A, Lin JC, Mai HQ, Zhang L, Guo Y, Lin AH, Sun Y, Ma J. Chen YP, et al. Among authors: chen l. Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):170-176. doi: 10.1016/j.ijrobp.2017.01.214. Epub 2017 Jan 29. Int J Radiat Oncol Biol Phys. 2017. PMID: 28586958 Review.
Neutropenia during the First Cycle of Induction Chemotherapy Is Prognostic for Poor Survival in Locoregionally Advanced Nasopharyngeal Carcinoma: A Real-World Study in an Endemic Area.
Xu C, Yang SP, Zhang Y, Tang LL, Zhou GQ, Liu X, Mao YP, Guo R, Li WF, Chen L, Lin AH, Sun Y, Ma J. Xu C, et al. Among authors: chen l. Cancer Res Treat. 2018 Jul;50(3):777-790. doi: 10.4143/crt.2017.255. Epub 2017 Jul 24. Cancer Res Treat. 2018. PMID: 28745036 Free PMC article.
Decreased Overall and Cancer-Specific Mortality with Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Treated by Intensity-modulated Radiotherapy: Multivariate Competing Risk Analysis.
Zhang J, Peng H, Chen L, Li WF, Mao YP, Liu LZ, Tian L, Guo Y, Sun Y, Ma J. Zhang J, et al. Among authors: chen l. J Cancer. 2017 Aug 3;8(13):2587-2594. doi: 10.7150/jca.20081. eCollection 2017. J Cancer. 2017. PMID: 28900496 Free PMC article.
The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis.
You R, Cao YS, Huang PY, Chen L, Yang Q, Liu YP, Zou X, Zhang YN, Jiang R, Zhang MX, Duan CY, Lin AH, Hong MH, Chen MY. You R, et al. Among authors: chen l, chen my. Theranostics. 2017 Oct 17;7(19):4825-4835. doi: 10.7150/thno.21815. eCollection 2017. Theranostics. 2017. PMID: 29187906 Free PMC article.
Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials.
Chen YP, Tang LL, Yang Q, Poh SS, Hui EP, Chan ATC, Ong WS, Tan T, Wee J, Li WF, Chen L, Ma BBY, Tong M, Tan SH, Cheah SL, Fong KW, Sommat K, Soong YL, Guo Y, Lin AH, Sun Y, Hong MH, Cao SM, Chen MY, Ma J. Chen YP, et al. Among authors: chen l, chen my. Clin Cancer Res. 2018 Apr 15;24(8):1824-1833. doi: 10.1158/1078-0432.CCR-17-2656. Epub 2018 Feb 5. Clin Cancer Res. 2018. PMID: 29431618
81,719 results
You have reached the last available page of results. Please see the User Guide for more information.